These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27134280)

  • 21. Use of methotrexate in patients with scleroderma and mixed connective tissue disease.
    Kowal-Bielecka O; Distler O
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S160-3. PubMed ID: 21044452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of oral methotrexate in the treatment of systemic sclerosis.
    Krishna Sumanth M; Sharma VK; Khaitan BK; Kapoor A; Tejasvi T
    Int J Dermatol; 2007 Feb; 46(2):218-23. PubMed ID: 17269983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclophosphamide treatment improves microvessel damage in systemic sclerosis.
    Caramaschi P; Volpe A; Pieropan S; Tinazzi I; Mahamid H; Bambara LM; Biasi D
    Clin Rheumatol; 2009 Apr; 28(4):391-5. PubMed ID: 19052833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination therapy with Bosentan and Sildenafil improves Raynaud's phenomenon and fosters the recovery of microvascular involvement in systemic sclerosis.
    Bellando-Randone S; Lepri G; Bruni C; Blagojevic J; Radicati A; Cometi L; De Paulis A; Matucci-Cerinic M; Guiducci S
    Clin Rheumatol; 2016 Jan; 35(1):127-32. PubMed ID: 26631100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disappearance of circulating autoantibodies to RNA polymerase III in a patient with systemic sclerosis successfully treated with corticosteroid and methotrexate.
    Tanahashi K; Sugiura K; Muro Y; Akiyama M
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1453-4. PubMed ID: 24916000
    [No Abstract]   [Full Text] [Related]  

  • 26. Low dose methotrexate treatment in systemic sclerosis.
    van den Hoogen FH; Boerbooms AM; van de Putte LB; Rasker JJ; van Venrooij WJ
    J Rheumatol; 1991 Nov; 18(11):1763-4. PubMed ID: 1787505
    [No Abstract]   [Full Text] [Related]  

  • 27. Seroconversion in patients with rheumatic diseases treated with immunomodulators or immunosuppressants, who were inadvertently revaccinated against yellow fever.
    Oliveira AC; Mota LM; Santos-Neto LL; Simões M; Martins-Filho OA; Tauil PL
    Arthritis Rheumatol; 2015 Feb; 67(2):582-3. PubMed ID: 25418753
    [No Abstract]   [Full Text] [Related]  

  • 28. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial.
    Burt RK; Shah SJ; Dill K; Grant T; Gheorghiade M; Schroeder J; Craig R; Hirano I; Marshall K; Ruderman E; Jovanovic B; Milanetti F; Jain S; Boyce K; Morgan A; Carr J; Barr W
    Lancet; 2011 Aug; 378(9790):498-506. PubMed ID: 21777972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group.
    Jordan S; Distler JH; Maurer B; Huscher D; van Laar JM; Allanore Y; Distler O;
    Ann Rheum Dis; 2015 Jun; 74(6):1188-94. PubMed ID: 24442885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to: 'Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab' by Avouac
    Guilpain P; Le Bihan C; Foulongne V; Taourel P; Pansu N; Maria ATJ; Jung B; Larcher R; Klouche K; Le Moing V
    Ann Rheum Dis; 2021 Mar; 80(3):e38. PubMed ID: 32503848
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy and safety of rituximab in systemic sclerosis: French retrospective study and literature review.
    Thiebaut M; Launay D; Rivière S; Mahévas T; Bellakhal S; Hachulla E; Fain O; Mekinian A
    Autoimmun Rev; 2018 Jun; 17(6):582-587. PubMed ID: 29635080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha interferon in systemic sclerosis.
    Shah VM; Mangat GK; Joshi VR
    J Assoc Physicians India; 2001 Jun; 49():676-7. PubMed ID: 11584956
    [No Abstract]   [Full Text] [Related]  

  • 33. Is there a role for B-cell depletion as therapy for scleroderma? A case report and review of the literature.
    Daoussis D; Liossis SN; Tsamandas AC; Kalogeropoulou C; Kazantzi A; Korfiatis P; Yiannopoulos G; Andonopoulos AP
    Semin Arthritis Rheum; 2010 Oct; 40(2):127-36. PubMed ID: 20004954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis.
    Bosello SL; De Luca G; Rucco M; Berardi G; Falcione M; Danza FM; Pirronti T; Ferraccioli G
    Semin Arthritis Rheum; 2015 Feb; 44(4):428-36. PubMed ID: 25300701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of iloprost on microvascular structure assessed by nailfold videocapillaroscopy: a pilot study.
    Shah P; Murray AK; Moore TL; Herrick AL
    J Rheumatol; 2011 Sep; 38(9):2079-80. PubMed ID: 21885525
    [No Abstract]   [Full Text] [Related]  

  • 36. Emerging therapies in systemic lupus erythematous: from clinical trial to the real life.
    Zhang H; Chambers W; Sciascia S; Cuadrado MJ
    Expert Rev Clin Pharmacol; 2016; 9(5):681-94. PubMed ID: 26907827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longterm effects of endothelin receptor antagonism on microvascular damage evaluated by nailfold capillaroscopic analysis in systemic sclerosis.
    Cutolo M; Zampogna G; Vremis L; Smith V; Pizzorni C; Sulli A
    J Rheumatol; 2013 Jan; 40(1):40-5. PubMed ID: 23118114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial.
    Allenbach Y; Guiguet M; Rigolet A; Marie I; Hachulla E; Drouot L; Jouen F; Jacquot S; Mariampillai K; Musset L; Grenier P; Devilliers H; Hij A; Boyer O; Herson S; Benveniste O
    PLoS One; 2015; 10(11):e0133702. PubMed ID: 26539981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful early rituximab treatment in a case of systemic lupus erythematosus with potentially fatal diffuse alveolar hemorrhage.
    Na JO; Chang SH; Seo KH; Choi JS; Lee HS; Lyu JW; Nah SS
    Respiration; 2015; 89(1):62-5. PubMed ID: 25531296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Widespread soft tissue calcification in systemic sclerosis, polymyositis, and polyarthritis.
    Hudowenz O; Klemm P; Lange U; Mueller-Ladner U
    Lancet; 2021 Jan; 397(10272):409. PubMed ID: 33516339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.